Navigation Links
IRCM researchers uncover a new function for an important player in the immune response
Date:3/27/2014

Montral, March 27, 2014 IRCM researchers led by Javier M. Di Noia, PhD, uncovered a new function of AID, a crucial enzyme for the immune response. The discovery, recently published by the scientific journal Proceedings of the National Academy of Sciences (PNAS), helps explain a rare genetic disorder that causes an immunodeficiency syndrome.

The Montral research team studies the enzyme AID, or activation-induced deaminase, that can be found in B lymphocytes (the group of white blood cells whose main function is to produce antibodies to fight against infections). AID creates deliberate mutations in DNA to modify the antibody genes, which is necessary to produce an appropriate immune response. However, inappropriate functioning of AID can also have harmful effects and lead to certain oncogenic (cancer-causing) mutations.

"One of AID's roles is to trigger antibody class switching, a critical mechanism for immune responses," explains Dr. Di Noia, Director of the Mechanisms of Genetic Diversity research unit at the IRCM. "Class switching is the process that allows a B cell to produce different classes of antibodies, so the immune system can respond to and eliminate a wide variety of antigens."

AID initiates a mechanism whereby a break occurs in the DNA, within the antibody genes, and a segment is removed. The free ends on either side of the removed fragment must be rejoined to repair the DNA strand and, thus, produce a new class of antibody.

"Not only is AID responsible for triggering class switching, but we also discovered that it facilitates DNA repair during this process," says Astrid Zahn, PhD, research associate in Dr. Di Noia's laboratory and first author of the study. "In addition, we identified which domain of the enzyme controls this novel activity. These findings show that AID provides a link between the DNA damage and repair steps during class switching."

"Our study also helps explain a rare disease known as hyper-IgM syndrome type 2 (HIGM2) that is caused by mutations affecting AID," adds Dr. Zahn. "The disease is part of a family of genetic disorders in which patients only produce Immunoglobin M (the default class of antibody produced by B lymphocytes), but none of the other classes of antibodies elicited during infections. This dramatically compromises the immune system's ability to fight infectious diseases."

In the human genome, two copies (or alleles) of a gene exist for every protein, one coming from each parent. HIGM2 is usually caused by a total AID deficiency because both alleles of the gene are inactivated. However, in about 10 per cent of HIGM2 patients, only one allele of AID is mutated. This mutated enzyme is therefore dominant, as it causes the disease despite the simultaneous presence of normal AID in the B cell. The researchers found that all mutated AID variants were specifically lacking the domain identified in their study as being important for DNA repair.

"In HIGM2 patients, the absence of this region makes AID exceptionally efficient at producing DNA damage but without the ability to initiate the necessary repair mechanisms," concludes Dr. Di Noia. "As a result, the mutated AID interferes with the normal mechanism of class switching and becomes toxic for B cells, thus causing the immunodeficiency syndrome."


'/>"/>
Contact: Julie Langelier
julie.langelier@ircm.qc.ca
514-987-5555
Institut de recherches cliniques de Montreal
Source:Eurekalert

Related biology news :

1. UGA researchers explore function of cancer-causing gene
2. Researchers present comprehensive roadmap of blood cells
3. UT Southwestern ob/gyn researchers studying genetic factors in premature births
4. Researchers issue state-of-the-state on genetic-based testing & treatment for breast cancer
5. Miscarriage clues identified in new DNA test according to researchers at Montefiore and Einstein
6. Researchers uncover allergy-cancer connection
7. Vanderbilt diabetes researchers track cells ability to regenerate
8. Researchers devise new, stretchable antenna for wearable health monitoring
9. Researchers find high acceptability of 3-colored raspberry jelly
10. Motion and muscles dont always work in lockstep, researchers find in surprising new study
11. New bilateral pilot opportunity will fund collaborations between US and UK bioscience researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2016)... 10, 2016   Unisys Corporation (NYSE: UIS ... (CBP) is testing its biometric identity solution at the ... to help identify certain non-U.S. citizens leaving the country. ... designed to help determine the efficiency and accuracy of using ... and will run until May 2016. --> ...
(Date:3/9/2016)... HAMBURG, Germany , March 9, 2016 ... African country,s government identified that more than 23,000 public ... name or had been receiving their salary unlawfully.    ... West African country,s government identified that more than 23,000 ... recorded name or had been receiving their salary unlawfully. ...
(Date:3/8/2016)... 2016   Valencell , the leading innovator ... has secured $11M in Series D financing. The ... venture fund being launched by UAE-based financial services ... investors TDF Ventures and WSJ Joshua Fund. Valencell ... triple-digit growth and accelerate its pioneering innovation in ...
Breaking Biology News(10 mins):
(Date:5/4/2016)... ... ... Proove Biosciences, Inc. , the commercial and research leader in personalized ... The partnership is designed to advance research in pain genetics in an effort to ... the new agreement, researchers at Proove Biosciences are able to collaborate with Luda Diatechnko, ...
(Date:5/4/2016)... New York , May 4, 2016 ... by Transparency Market Research "Metabolomics Market - Global Industry ... 2024", the metabolomics market is anticipated to expand at ... reach USD 2,494.8 million by 2024. Metabolomics ... as metabolites, within cells, biofluids, tissues or organisms. Together, ...
(Date:5/3/2016)... , May 3, 2016 ... (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD ... (Academics Institutes, Diagnostics Centers), Fabrication Technology (Microarrays, ... MarketsandMarkets, the market is expected to reach ... 7.63 Billion in 2015, growing at a ...
(Date:5/3/2016)... Boston, Massachusetts (PRWEB) , ... May 03, 2016 ... ... communities will gather at Boston CEO 2016 on May 31st and June 1st ... off-the-record networking forum for leading executives in the life sciences, offering exclusive access ...
Breaking Biology Technology: